I prefer Pfizer’s shares over Novavax

Seres Therapeutics: “You are a younger person and you are new and I think you can buy it. For an older person it is too speculative because the company does not make money. However, I like your call.”

ViacomCBS: “It’s OK. I think the whole business is under attack. You can name one of these. I think it’s perfectly OK. I mean, it’s well run, but it’s just OK.”

Novavax: “They came as gangbusters. We all thought they were going to be the same. I like Pfizer. Pfizer has the pill on the way too. It̵[ads1]7;s the affordable way. I feel safe with Pfizer.”

ODP Corporation: “No, I can buy anything I want on Amazon. I do not need that company. It’s an Amazon roadkill.”

GrowGeneration: “Well, we were growing in our teens, and when it came to the $ 40s and $ 50s, we said, ‘We’ve had enough. We’ve made too much money, let’s not be greedy.’ Bulls make money, bears make money, pigs are slaughtered, and we said sell and we have never looked back. “

Canopy Growth: “At this point, $ 9, I guess I would [be a buyer]. My problem here is that this did not have a good quarter. It’s not going so well. … I do not like the cannabis industry. I just do not. I think it was an over-hyped business, not unlike what we see right now in the gambling industry, which is just brutal. “

Palantir: “Cult stock, cult stock, cult stock. Cult stocks don’t work, OK? … We joked about it, we traded it, but no. There’s a cult stock right now. It does not work.”

ContextLogic: “We actually think this company is a decent company and they’re throwing it away. I mean look, you buy it for $ 3, can it go to zero? I guess so, but it’s a good one. [speculative play]. “

Register now for the CNBC Investing Club to follow Jim Cramers every move in the market.